Abstract
Articular cartilage has limited potential for self-repair, and cell-based strategies combining scaffolds and chondrocytes are currently used to treat cartilage injuries. However, achieving a satisfying level of cell redifferentiation following expansion remains challenging. Hydrogels and perfusion bioreactors are known to exert beneficial cues on chondrocytes; however, the effect of a combined approach on the quality of cartilage matrix deposited by cells is not fully understood. Here, we combined soluble factors (BMP-2, Insulin, and Triiodothyronine, that is, BIT), fibrin hydrogel, direct perfusion and human articular chondrocytes (HACs) to engineer large cartilage tissues. Following cell expansion, cells were embedded in fibrin gels and cultivated under either static or perfusion conditions. The nature of the matrix synthesized was assessed by Western blotting and immunohistochemistry. The stability of cartilage grafts and integration with native tissue were also investigated by subcutaneous implantation of human osteochondral cylinders in nude mice. Perfusion preconditioning improved matrix quality and spatial distribution. Specifically, perfusion preconditioning resulted in a matrix rich in type II collagen but not in type I collagen, indicating the reconstruction of hyaline cartilage. Remarkably, the production of type VI collagen, the main component of the pericellular matrix, was also increased, indicating that chondrocytes were connecting to the hyaline matrix they produced.
Highlights
Articular cartilage is a hyaline type of cartilage covering the extremities of long bones in synovial joints
We first evaluated the distribution of the neo-synthetized cartilage extracellular matrix (ECM) produced by human articular chondrocytes (HACs) in fibrin hydrogels
To provide further evidence that perfusion of HACs encapsulated in fibrin hydrogel and treated with BIT enhances the chondrogenic activity of chondrocytes, we looked for Sox9 production
Summary
Articular cartilage is a hyaline type of cartilage covering the extremities of long bones in synovial joints. The avascular nature of cartilage together with the low metabolic rate of the chondrocytes limit its intrinsic capability for self-repairing [2]. Current strategies for repairing articular cartilage include microfracture (i.e., marrow stimulation), mosaicplasty (i.e., osteochondral autograft), and autologous chondrocyte implantation (ACI) [3]. Microfracture and mosaicplasty remain unsatisfactory treatments due to the occurrence of type I collagen-rich fibrocartilage in the repaired defect [4,5]. ACI is a cell-based surgical procedure currently practiced as a popular second-line treatment for relatively large articular cartilage lesions [6,7]. Hydrogels are excellent candidates for this due to their ability to encapsulate the cells, along with a high intrinsic water content (60–90%) [10], a feature found in native cartilage [11] which offers the tissue its “shock absorber” capabilities
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.